Ep0162 50615 — Boston, Massachusetts

Ep0162 50615 is a clinical research site located in Boston, Massachusetts, United States 02118.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Ep0162 50615 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Stereotypical Prolonged Seizures.

Sponsors: UCB Biopharma SRL.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Ep0162 50615?

Ep0162 50615 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Ep0162 50615 conducted?

Ep0162 50615 has 1 clinical trials on record, with 1 currently active. Their work covers Stereotypical Prolonged Seizures.

Is Ep0162 50615 accredited by Crixeo Health?

Ep0162 50615 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Ep0162 50615?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.